Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.

Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma. Abstract Text:

Jerzy Kosowicz,Renata Miko?ajczak,Rafa? Czepczy?ski,Katarzyna Ziemnicka,Maria Gryczy?ska,Jerzy Sowi?ski,Jerzy Kosowicz,Renata Miko?ajczak,Rafa? Czepczy?ski,Katarzyna Ziemnicka,Maria Gryczy?ska,Jerzy Sowi?ski,

Somatostatin and gastrin receptors are overexpressed in medullary thyroid carcinoma (MTC) cells; hence, both of them are potential targets for peptide receptor scintigraphy and radiotherapy. Therefore, the aim of our study was to assess the clinical value of two technetium-99m-labeled peptides, a new gastrin analog, the EDDA/HYNIC-(D)Glu-octagastrin and a somatostatin analog, EDDA/HYNIC-Tyr(3)-octreotide (EDDA/HYNIC-TOC) for scintigraphy in patients with MTC to detect recurrences and metastases and select patients for peptide receptor radiotherapy. MATERIAL AND METHODS: Thirty (30) patients, 20 females and 10 males, 22-83 years of age (mean, 52.7) with the diagnosis of MTC in different stages of the disease (preoperative, postsurgery, remission, recurrence, or metastatic disease) were included in this study. Before surgery, in all patients serum calcitonin concentrations were elevated. The diagnosis of MTC was confirmed in all cases by histopathology of the removed tumor and immunohistochemical staining giving positive reactions for calcitonin and chromogranin A. Imaging studies using (99m)Tc-EDDA/HYNIC-TOC and a new minigastrin analog, (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin, were performed in each patient and the results compared with each other and with other imaging methods. Scans of the whole body, head, neck, and chest were performed 2 and 4 hours after injections of the tracer, 500-600 MBq in each case, using a double-head Varicam (Elscint, Israel) gamma camera. RESULTS: (99m)Tc-EDDA/HYNIC-TOC detected somatostatin receptor-positive lesions in 20 patients with MTC, whereas (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin displayed gastrin receptors in 11 patients. In 9 cases, the scans were positive in both methods, although in 2 cases different pathologic foci were visualized. In 12 cases, only (99m)Tc-EDDA/HYNIC-TOC scintigraphy was positive, whereas in 3 other cases only (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin revealed pathologic lesions. CONCLUSIONS: Scintigraphy using (99m)Tc-HYNIC-TOC permits the visualization of somatostatin receptor-positive MTC in the majority of cases. The new gastrin analog, (99m)Tc-HYNIC-(D)Glu-octagastrin, is well tolerated, shows no renal retention, and in some cases of MTC, provides additional information on the expression of gastrin receptors. However, inferior quality of octagastrin scans indicates the need for further improvement of this radiopeptide.

Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma. Publishing Authors By Initials

J Kosowicz,R Miko?ajczak,R Czepczy?ski,K Ziemnicka,M Gryczy?ska,J Sowi?ski,J Kosowicz,R Miko?ajczak,R Czepczy?ski,K Ziemnicka,M Gryczy?ska,J Sowi?ski,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Cancer biotherapy & radiopharmaceuticals

VOLUME: 22

Page Numbers: 613-28

Journal Abbreviation: Cancer Biother. Radiopharm.

ISSN: 1084-9785

DAY: 5

MONTH: Oct

YEAR: 2007

Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9605408

Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.

AFFILIATION: Department of Endocrinology, Metabolism and Internal Diseases, Pozna? University of Medical Sciences, Pozna?, Poland. jkosowicz@poczta.fm

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Biother Radiopharm

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Two peptide receptor ligands 99mTc-EDDA/HYNIC-Tyr3-octreotide and 99mTc-EDDA/HYNIC-DGlu-octagastrin for scintigraphy of medullary thyroid carcinoma Related Publications

• Circulating leptin levels are not influenced by thyroid status in hypothyroid and euthyroid women.
• Preliminary results of combined application of radioisotopes and biphosphonates in the management of pain associated with osteoblastic-osteolytic bone metastases of breast cancer.
• Serum Adiponectin Concentrations are not Related to Glycosylated Hemoglobin Levels (HbA1c) in Obese Diabetic and Non-diabetic Caucasians.
• The Y111 H (T415C) Polymorphism in Exon 3 of the Gene Encoding Adiponectin is Uncommon in Polish Obese Patients.
• The effectivness of strontium 89 in palliative therapy of painful prostate cancer bone metastases.
• Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.
• [A case of Abrikosov tumor of the larynx]
• [A case of calcinosis in the maxillary sinus]
• [A case of localized type of amyloidosis restricted to the nasopharynx]
• [A case of teratoma of the middle pharynx in an infant]
• [A case of teratoma of the neck in an 8-year-old child]
• [Acid mucopolysaccharides in connective tissue stroma surrounding the carcinomatous focus in patients with laryngeal cancer and their prognostic value]
• [Amyloidosis of the larynx]
• [Case of Wegener's disease with a fulminant course]
• [Case of large cyst of the pharynx and pharyngeal space]
• [Case of tumor of the sphenopalatine and subtemporal fossa]
• [Effect of the substitute treatment of hypothyroidism on echocardiographic changes]
• [Harmful effect of noise on the inner ear and auditory pathways in the guinea pig]
• [Histoenzymatic studies of laryngeal chondrosarcoma]
• [Lateral pharyngeal cyst]
• [Legal status of doctors--nationals of countries belonging to the European Economic Community]
• [Limited form of amyloidosis of the respiratory tract]
• [Malherbe's epithelioma of the preauricular area]
• [Management of cartilaginous tumors of the larynx]
• [Microscopic examination of nasopharyngeal mucosa in autopsy material]
• [Non-small cell lung cancer presenting under the mask of a primary adrenal cancer--case report]
• [On the behavior of tissues neighboring with the neoplastic infiltration in the larynx]
• [Preoperative hormonal therapy in patients with juvenile fibroma]
• [The incidence of the pituitary autoantibodies in Graves' disease]
• [Thyroid function in patients with laryngeal carcinoma treated surgically and with radiotherapy]